Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Denis M. Schewe, Beat Bornhäuser et al.|Blood Advances|2022Cited by 20
Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemiaAnna Saorin, Beat Bornhäuser, Anna Dehler et al.|Blood|2025Cited by 11
MSC.sensor: capturing cancer cell interactions with stroma for functional profilingYun Huang, Jean‐Pierre Bourquin, Aneta Drakul et al.|Research Square|2023Cited by 1
P331: THE ONCOGENIC TRANSCRIPTION FACTOR TCF3::HLF MARKS A DISTINCT ENHANCER-PROMOTER INTERACTION NETWORK IN T(17;19) POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAValdemar Priebe, Jean‐Pierre Bourquin, Aneta Drakul et al.|HemaSphere|2023Cited by 1
TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemiaValdemar Priebe, Jean‐Pierre Bourquin, Bartimée Galvan et al.|Science Advances|2026Cited by 1